Page last updated: 2024-09-04

sonepiprazole and levodopa

sonepiprazole has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(sonepiprazole)
Trials
(sonepiprazole)
Recent Studies (post-2010)
(sonepiprazole)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
201517,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomysonepiprazole (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capiris, T; Connor, DT; Heffner, TG; MacKenzie, RG; Miller, SR; Pugsley, TA; Unangst, PC; Wise, LD1

Other Studies

1 other study(ies) available for sonepiprazole and levodopa

ArticleYear
Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agents.
    Journal of medicinal chemistry, 1997, Aug-15, Volume: 40, Issue:17

    Topics: Animals; Antipsychotic Agents; CHO Cells; Cloning, Molecular; Cricetinae; Dopamine D2 Receptor Antagonists; Humans; Kinetics; Levodopa; Models, Chemical; Piperazines; Pyridines; Pyridones; Pyrroles; Rats; Receptors, Dopamine D2; Receptors, Dopamine D4; Structure-Activity Relationship; Sulfonamides

1997